pdCas9-NED Citations (3)

Originally described in: Establishment of Cell Lines Stably Expressing dCas9-Fusions to Address Kinetics of Epigenetic Editing.
Goubert D, Koncz M, Kiss A, Rots MG Methods Mol Biol. 2018;1767:395-415. doi: 10.1007/978-1-4939-7774-1_22. PubMed Journal

---

Articles Citing pdCas9-NED

Articles
KRAB-Induced Heterochromatin Effectively Silences PLOD2 Gene Expression in Somatic Cells and is Resilient to TGFbeta1 Activation. Gjaltema RAF, Goubert D, Huisman C, Pilar Garcia Tobilla CD, Koncz M, Jellema PG, Wu D, Brouwer U, Kiss A, Verschure PJ, Bank RA, Rots MG. Int J Mol Sci. 2020 May 21;21(10). pii: ijms21103634. doi: 10.3390/ijms21103634. PubMed
Functional Validation of the Putative Oncogenic Activity of PLAU. Sarno F, Goubert D, Logie E, Rutten MGS, Koncz M, Deben C, Niemarkt AE, Altucci L, Verschure PJ, Kiss A, Berghe WV, Rots MG. Biomedicines. 2022 Dec 30;11(1):102. doi: 10.3390/biomedicines11010102. PubMed
Targeted epigenetic silencing of UCHL1 expression suppresses collagen-1 production in human lung epithelial cells. Wu DD, Lau ATY, Xu YM, Reinders-Luinge M, Koncz M, Kiss A, Timens W, Rots MG, Hylkema MN. Epigenetics. 2023 Dec;18(1):2175522. doi: 10.1080/15592294.2023.2175522. Epub 2023 Feb 22. PubMed

If you have published an article using this material, please email us at to have your article added to this page.